On July 21, the S&P 500 closed above its 20-day moving average for 60 straight days. Investors use moving averages to chart levels that could indicate some kind of breakout, meaning stocks heading higher. It's used more by technical strategists, but can be useful for all investors when it comes to identifying trends or sentiment.

The S&P 500 has reached a very high level of concentration, with the top 10 stocks driving 54% of its market cap gains since January 2021.

Wall Street is coming off a winning week fueled by strong earnings and recent deals between the U.S. and its trading partners.

Is the stock market's record-setting rally running out of steam? The S&P 500 and Nasdaq Composite on Tuesday were coming close to turning positive in early afternoon trading but have failed to break through.

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Friday. U.S. stocks settled higher on Friday, with the S&P 500 notching its 14th record close of the year as optimism over corporate earnings and progress on global trade talks provided support for risk assets.

U.S. stocks dipped Tuesday and broke Wall Street's record-breaking, weeklong run. The post Dow Drops 205, Nasdaq Loses 80, S&P 500 Falls 19 appeared first on TV News Check. The post Dow Drops 205, Nasdaq Loses 80,

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major Wall Street brokerages, betting on easing trade tensions and strong corporate earnings.

Friday marked another winning day for the S&P 500 and Nasdaq, as both indexes posted fresh all-time intraday and closing highs.

The S&P 500 is a market cap-weighted index, which includes roughly the 500 largest U.S. stocks spanning 11 sectors. The S&P 500 Equal Weight Index includes the same constituents as the S&P 500, but each company is equally weighted at a fixed weight. So how do these two indexes match up against each other this year?

The S&P 500 added 0.5% on Monday, June 30, closing the second quarter at record levels amid optimism about trade talks.

Novo Nordisk ( NVO 1.34%) and Regeneron Pharmaceuticals ( REGN -0.27%), two leading drugmakers, have underperformed for most of the year, significantly lagging the broader market. These healthcare giants are facing some headwinds, but does that mean investors should steer clear of them?

If the S&P 500 has been such a great investment, surely adding a few smart tweaks should make it even better, right? That’s been the theory behind dozens of factor-based spinoffs.